Bioage Labs Inc (BIOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Operating Expenses | 78,194 | 48,400 |
| Operating Income | -78,194 | -48,400 |
| Interest Expense | 2,367 | 7,794 |
| Other Income | 9,452 | -7,660 |
| Pre-tax Income | -71,109 | -63,854 |
| Net Income Continuous | -71,109 | -63,854 |
| Net Income | $-71,109 | $-63,854 |
| EPS Basic Total Ops | -6.63 | -38.17 |
| EPS Basic Continuous Ops | -6.63 | -38.17 |
| EPS Diluted Total Ops | -6.63 | -38.17 |
| EPS Diluted Continuous Ops | -6.63 | -38.17 |
| EPS Diluted Before Non-Recurring Items | -6.63 | N/A |
| EBITDA(a) | $-78,027 | $-48,238 |